Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study.
Saved in:
| Title: | Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study. |
|---|---|
| Authors: | Xiu J; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China., Yao X; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China., Sun Y; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China., Xu S; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China., Wang C; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China., Duan H; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China., Yan X; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Nov 17; Vol. 16, pp. 1654830. Date of Electronic Publication: 2025 Nov 17 (Print Publication: 2025). |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1654830 |
